These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11345011)

  • 1. Motor neuron disease.
    Jackson CE; Rosenfeld J
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):335-52, ix-x. PubMed ID: 11345011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis.
    Jackson CE; Bryan WW
    Semin Neurol; 1998; 18(1):27-39. PubMed ID: 9562665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cotreatment of amyotrophic lateral sclerosis patients].
    Iwasaki Y; Ikeda K
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1253-5. PubMed ID: 10791091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease.
    Ishiyama T; Okada R; Nishibe H; Mitsumoto H; Nakayama C
    Brain Res; 2004 Sep; 1019(1-2):226-36. PubMed ID: 15306257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor neuron disease associated with copper deficiency.
    Weihl CC; Lopate G
    Muscle Nerve; 2006 Dec; 34(6):789-93. PubMed ID: 16929546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-based treatment of motor neuron diseases.
    Federici T; Boulis NM
    Muscle Nerve; 2006 Mar; 33(3):302-23. PubMed ID: 16228969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amyotrophic lateral sclerosis].
    Moriwaka F
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):21-5. PubMed ID: 9086359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
    Yanagisawa N; Shindo M
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1329-30. PubMed ID: 9128396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preface: the state of the science of all motor neuron diseases.
    Weiss MD; Carter GT
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):xix-xx. PubMed ID: 18625405
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical differentiation between primary lateral sclerosis and upper motor neuron predominant amyotrophic lateral sclerosis.
    Gotkine M; Argov Z
    Arch Neurol; 2007 Oct; 64(10):1545; author reply 1545. PubMed ID: 17923644
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis.
    Sach M; Winkler G; Glauche V; Liepert J; Heimbach B; Koch MA; Büchel C; Weiller C
    Brain; 2004 Feb; 127(Pt 2):340-50. PubMed ID: 14607785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do the benefits of currently available treatments justify early diagnosis and announcement? Arguments for.
    Cashman NR
    Neurology; 1999; 53(8 Suppl 5):S50-2; discussion S55-7. PubMed ID: 10560639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature.
    Tan CF; Kakita A; Piao YS; Kikugawa K; Endo K; Tanaka M; Okamoto K; Takahashi H
    Acta Neuropathol; 2003 Jun; 105(6):615-20. PubMed ID: 12734667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
    Iwata NK
    Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.
    Wang S; Melhem ER
    Ann N Y Acad Sci; 2005 Dec; 1064():61-77. PubMed ID: 16394148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum?
    Strong MJ; Gordon PH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):8-16. PubMed ID: 16036421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Arguments against.
    Ludolph AC; Riepe MW
    Neurology; 1999; 53(8 Suppl 5):S46-9; discussion S55-7. PubMed ID: 10560638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.